← Back to Clinical Trials
Recruiting NCT07224646

NCT07224646 Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07224646
Status Recruiting
Phase
Sponsor Universidade Federal de Sao Carlos
Condition Athletic Performance
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2025-09-04
Primary Completion 2026-08

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Whole-Body Photobiomodulation (PBM) (Active PBM)Sham PBM

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2025-09-04 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of whole-body photobiomodulation on professional soccer players during a state championship. The primary question is whether photobiomodulation improves recovery, reduces muscle fatigue, and enhances performance compared to standard training without photobiomodulation.

Eligibility Criteria

Inclusion Criteria: * Male professional soccer players currently competing in the championship * Age 18-35 years * Training frequency ≥5 times per week * Able to attend all PBM/sham sessions and all assessments during the 8-week intervention * Signed informed consent Exclusion Criteria: * Lower-limb musculoskeletal injury in the last 6 months or currently receiving treatment * Current use of phototherapy or any other recovery-enhancing modality * Chronic medical conditions that may affect performance or recovery * Known sensitivity or contraindication to light-based therapies * Inability to comply with the intervention or training schedule

Contact & Investigator

Central Contact

Italo A Oliveira, MSc

✉ italoao@estudante.ufscar.br

📞 +55 19 997190361

Principal Investigator

Italo A Oliveira, MSc

PRINCIPAL INVESTIGATOR

UFSCAR

Frequently Asked Questions

Who can join the NCT07224646 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 35 Years, studying Athletic Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07224646 currently recruiting?

Yes, NCT07224646 is actively recruiting participants. Contact the research team at italoao@estudante.ufscar.br for enrollment information.

Where is the NCT07224646 trial being conducted?

This trial is being conducted at Porto Feliz, Brazil.

Who is sponsoring the NCT07224646 clinical trial?

NCT07224646 is sponsored by Universidade Federal de Sao Carlos. The principal investigator is Italo A Oliveira, MSc at UFSCAR. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology